June 3, 2020: On February 11, 2020, HHS issued a concept (PDF, 162 KB) to condition stakeholders holding antiviral drug products and solutions (Tamiflu and Relenza) about supplemental expiry relationship extensions for properly held item. “…Depending on FDA's assessment of scientific facts, FDA has concluded for unexpected emergency responses that, https://listing-expired-need-to-s81281.newsbloger.com/33665937/facts-about-expired-listing-cards-revealed